| FWGIX | RWIGX | FWGIX / RWIGX | |
| Total Expense Ratio | 0.41 | 0.41 | 100% |
| Annual Report Gross Expense Ratio | 0.41 | 0.41 | 100% |
| Fund Existence | 9 years | 17 years | - |
| Gain YTD | 14.614 | 14.625 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 142B | 142B | 100% |
| Annual Yield % from dividends | 1.64 | 1.64 | 100% |
| Returns for 1 year | 12.59 | 12.59 | 100% |
| Returns for 3 years | 47.50 | 47.53 | 100% |
| Returns for 5 years | 32.83 | 32.85 | 100% |
| Returns for 10 years | N/A | 76.97 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 40.32 | 0.81 | +2.05% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| RSP | 193.79 | 0.70 | +0.36% |
| Invesco S&P 500® Equal Weight ETF | |||
| APCB | 29.67 | 0.09 | +0.31% |
| ActivePassive Core Bond ETF | |||
| DECP | 30.66 | 0.07 | +0.23% |
| PGIM S&P 500 Buffer 12 ETF - Dec | |||
| APMU | 25.07 | 0.02 | +0.08% |
| ActivePassive Intermediate Mcpl Bd ETF | |||